• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: Beurs-Advies

Teva stock crashes on 2Q earnings disaster; run for the hills, or buy at fire sale price?

Steve Walker    August 9, 2017 November 6, 2017    1 Comment on Teva stock crashes on 2Q earnings disaster; run for the hills, or buy at fire sale price?

The News: Teva Pharmaceutical Industries Ltd., which has been without a permanent CEO for six months, plunged $11.74, or 36% last week, to $20.60–the most in almost two decades. The… Read more »

Corporate, Investment, Pharmaceuticals    Actavis, Allergan PLC, Bastian Gries, Beurs-Advies, Bill Mann, Bloomberg, Bloomberg Intelligence, Carol Levenson, Copaxone, Elizabeth Krutoholow, Erez Vigodman, Gimme Credit, Motley Fool, Seeking Alpha, Teva Pharmaceutical Industries Ltd., U.S. Food and Drug Administration

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Top Stories for Week of January 18, 2021
  • Top Stories for Week of January 11, 2021
  • Top Stories for Week of January 4, 2021
  • Top Stories for Week of December 21, 2020
    • China records more than 2,000 new coronavirus cases in 24 hours; CDC director says CIVUD-19 probably with us beyond this
    • Top Stories for Week of June 8, 2020
    • Top Stories for Week of August 10, 2020
    • Top Stories for Week of October 5, 2020
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress